Olesoxime Completed Phase 2 Trials for Chemotherapy Induced Peripheral Neuropathy (CIPN) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00876538Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy